ARTES Biotechnology - Services for Recombinant Strain Development in Microbial Expression Systems
Services for Recombinant Strain Development in Microbial Expression Systems
ARTES Biotechnology GmbH, a profitable German biotech company, is offering R&D services for recombinant strain development in microbial expression systems. The champion amongst them is the patent protected yeast Hansenula polymorpha.
ARTES Biotechnology has worldwide exclusive licensing rights on this superior expression technology for various application fields. ARTES' staff has more than 15 years experience in commercial project management in heterologous gene expression and process development, especially in the handling and exploitation of the Hansenula polymorpha technology platform.
ARTES' customers include multinational players such as DSM Nutritional Products (previously Roche) and Danisco as well as small and middle sized companies. Protein expression in Hansenula | Artes Biotechnology. ARTES has strategic collaboration partners around the world to offer customer tailored service packages in the field of recombinant protein production such as:
- Gene analysis and design
- Production strain selection
- Fermentation development
- Downstream processing
- Process upscale
- Large scale cGMP production
With its collaboration network ARTES is the ideal partner for complete research and development from gene to product and for the implementation of your production process. To ensure the highest quality in project progress and documentation ARTES offers consultation and supervision service during the defined project period.
ARTES Biotechnology GmbH
Elisabeth-Selbert-Str. 9,
40764 Langenfeld, Germany
Tel: +49 (0) 2173 27587-0
Fax: +49 (0) 2173 27587-77
Delicious
Digg
Facebook
LinkedIn
Reddit
Stumble
Viadeo